M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway

被引:63
作者
Lv, Juan [1 ]
Liu, Chao [1 ]
Chen, Fu-Kun [1 ]
Feng, Zhi-Ping [1 ]
Jia, Li [1 ]
Liu, Peng-Jie [1 ]
Yang, Zhi-Xian [1 ]
Hou, Fei [1 ]
Deng, Zhi-Yong [1 ]
机构
[1] Kunming Med Univ, Dept Nucl Med, Affiliated Hosp 3, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
M2-like TAMs; IGF; PI3K; AKT; mTOR pathway; thyroid cancer; cancer stemness; EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA-CELLS; PROGRESSION; GROWTH; ANGIOGENESIS; POLARIZATION; MODEL; AXIS;
D O I
10.3892/mmr.2021.12249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
M2-like tumour-associated macrophages (TAMs) have been demonstrated to promote the growth of anaplastic thyroid carcinoma (ATC). However, the underlying mechanism of M2-like TAMs in ATC remains unclear. Thus, in the present study, the role and mechanism of M2-like TAMs in ATC were investigated. M2-like TAMs were induced by treatment with PMA, plus IL-4 and IL-13, and identified by flow cytometry. Transwell and sphere formation assays were applied to assess the invasion and stemness of ATC cells. The expression levels of insulin-like growth factor (IGF)-1 and IGF-2 were examined by ELISA and reverse transcription-quantitative PCR. Proteins related to the epithelial-mesenchymal transition (EMT), stemness and the PI3K/AKT/mTOR pathway were examined via western blotting. Immunohistochemistry (IHC) was used to detect the expression of the M2-like TAM markers CD68 and CD206 in ATC tissues and thyroid adenoma tissues. It was found that treatment with PMA plus IL-4 and IL-13 successfully induced M2-like TAMs. Following co-culture with M2-like TAMs, the invasive ability and stemness of ATC cells were significantly increased. The expression levels of the EMT-related markers N-cadherin and Vimentin, the stemness-related markers Oct4, Sox2 and CD133, and the insulin receptor (IR)-A/IGF1 receptor (IGF1R) were markedly upregulated, whereas E-cadherin expression was significantly decreased. In addition, the production of IGF-1 and IGF-2 was significantly increased. Of note, exogenous IGF-1/IGF-2 promoted the invasion and stemness of C643 cells, whereas blocking IGF-1 and IGF-2 inhibited metastasis and stemness by repressing IR-A/IGF-1R-mediated PI3K/AKT/mTOR signalling in the co-culture system. IHC results showed that the expression of CD68 and CD206 was obviously increased in ATC tissues. To conclude, M2-like TAMs accelerated the metastasis and increased the stemness of ATC cells, and the underlying mechanism may be related to the section of IGF by M2-like TAMs, which activates the IR-A/IGF1R-mediated PI3K/AKT/mTOR signalling pathway.
引用
收藏
页数:10
相关论文
共 48 条
[1]  
Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO
[2]  
2-L
[3]  
Blanpain C., 2019, RADIOTHER ONCOL, V106, pS198
[4]   Insulin Receptor Signaling in Normal and Insulin-Resistant States [J].
Boucher, Jeremie ;
Kleinridders, Andre ;
Kahn, C. Ronald .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2014, 6 (01)
[5]   Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma [J].
Caillou, Bernard ;
Talbot, Monique ;
Weyemi, Urbain ;
Pioche-Durieu, Catherine ;
Al Ghuzlan, Abir ;
Bidart, Jean Michel ;
Chouaib, Salem ;
Schlumberger, Martin ;
Dupuy, Corinne .
PLOS ONE, 2011, 6 (07)
[6]  
Caras I, 2011, TUMORI J, V97, P647, DOI 10.1700/989.10726
[7]   Cancer stem cells Role in tumor growth, recurrence, metastasis, and treatment resistance [J].
Chang, Jenny C. .
MEDICINE, 2016, 95 :S20-S25
[8]   THP-1 cell line: An in vitro cell model for immune modulation approach [J].
Chanput, Wasaporn ;
Mes, Jurriaan J. ;
Wichers, Harry J. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 23 (01) :37-45
[9]   The IGF-I axis in thyroid carcinoma [J].
Ciampolillo, A. ;
De Tullio, C. ;
Perlino, E. ;
Maiorano, E. .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (07) :729-735
[10]   Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway [J].
Fu, Jiao ;
Lv, Hongjun ;
Guan, Haixia ;
Ma, Xiaoying ;
Ji, Meiju ;
He, Nongyue ;
Shi, Bingyin ;
Hou, Peng .
BMC CANCER, 2013, 13